AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (143.9 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Overview of ethical issues for conducting neuroprotective clinical trials in patients with spinal cord injury

Hooshang Saberi1,2( ), Nazi Derakhshanrad1, Mahsa Ghajarzadeh1
Brain and Spinal Cord Injury Research Center, Imam Khomeini Hospital,
Department of Neurosurgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Show Author Information

Abstract

Animals have been used in medical and biological researches worldwide for long time. Almost all of these studies are published with the hope of clinical application. However, there are meticulous criteria considering results of animal studies in clinical trials of human beings. In recent years, the number of experimental research in animal models of spinal cord injury has been growing. However, there is no warranty for translation of experimental studies into clinical practice. Certain protocols should be considered in all phases of conducting clinical trials such as study design, data gathering, and analysis. In this article, we comprehensively review different aspects of ethical issues in translating results of animal studies into clinical application, especially in patients with spinal cord injury.

References

【1】
【1】
 
 
Journal of Neurorestoratology
Pages 97-100

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Saberi H, Derakhshanrad N, Ghajarzadeh M. Overview of ethical issues for conducting neuroprotective clinical trials in patients with spinal cord injury. Journal of Neurorestoratology, 2015, 3(1): 97-100. https://doi.org/10.2147/JN.S74137

1088

Views

32

Downloads

4

Crossref

3

Web of Science

0

Scopus

Published: 06 May 2015
© 2015 The Author(s).

© 2015 Saberi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php